Dosage prescribing and plasma oxipurinol levels in patients receiving allopurinol therapy
- 1 October 1990
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 39 (4) , 419-421
- https://doi.org/10.1007/bf00315424
Abstract
This study examined dosage prescribing patterns and steady-state oxipurinol plasma concentrations in 66 patients receiving chronic allopurinol therapy. Most patients (65%) were taking 300 mg allopurinol daily, although renal impairment was common. Using published guidelines, it was estimated that 35% of patients were receiving excessive dosages of allopurinol. Consequently, the plasma oxipurinol concentrations were often very high (mean (SD) was 156 (109) μmol·1−1). Accumulation of oxipurinol was inversely related to renal function. Plasma concentrations of oxipurinol and urate were not significantly related. However, most patients with oxipurinol concentrations of up to 100 μmol·1−1 had urate concentrations within the normal reference range.Keywords
This publication has 8 references indexed in Scilit:
- Allopurinol dosage selection: relationships between dose and plasma oxipurinol and urate concentrations and urinary urate excretion.British Journal of Clinical Pharmacology, 1988
- PLASMA OXIPURINOL CONCENTRATIONS DURING ALLOPURINOL THERAPYRheumatology, 1987
- Use and abuse of allopurinol.BMJ, 1987
- The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortalityArthritis & Rheumatism, 1986
- Clinical Pharmacokinetics of AllopurinolClinical Pharmacokinetics, 1986
- Simultaneous determination of allopurinol, oxipurinol, hypoxanthine and xanthine in biological fluids by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1984
- Severe allopurinol toxicityThe American Journal of Medicine, 1984
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976